Compass Therapeutics to Participate in Upcoming Investor Events
Compass Therapeutics (Nasdaq: CMPX), a clinical-stage oncology-focused biopharmaceutical company, has announced its participation in two major investor events in September 2024. The company will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 9 at 11:00 AM ET in New York. Additionally, Compass will participate in the Cantor Global Healthcare Conference on September 17 at 8:35 AM ET, also in New York.
Both presentations will be available via webcast, with links provided for each event. Investors and interested parties can access the webcasts through the specified URLs. The presentations will be archived for 90 days on Compass Therapeutics' Events page, allowing for extended viewing opportunities. These events provide a platform for Compass to showcase its progress in developing antibody-based therapeutics for oncology applications.
Compass Therapeutics (Nasdaq: CMPX), un'azienda biofarmaceutica in fase clinica focalizzata sull'oncologia, ha annunciato la sua partecipazione a due eventi importanti per investitori nel settembre 2024. L'azienda presenterà al 26° Annual Global Investment Conference di H.C. Wainwright il 9 settembre alle 11:00 AM ET a New York. Inoltre, Compass parteciperà al Cantor Global Healthcare Conference il 17 settembre alle 8:35 AM ET, sempre a New York.
Entrambe le presentazioni saranno disponibili tramite webcast, con i link forniti per ciascun evento. Gli investitori e le parti interessate possono accedere ai webcast tramite gli URL specificati. Le presentazioni saranno archiviate per 90 giorni sulla pagina Eventi di Compass Therapeutics, permettendo opportunità di visualizzazione prolungate. Questi eventi offrono una piattaforma per Compass per mettere in mostra i suoi progressi nello sviluppo di terapeutiche a base di anticorpi per applicazioni oncologiche.
Compass Therapeutics (Nasdaq: CMPX), una empresa biofarmacéutica enfocada en oncología en etapa clínica, ha anunciado su participación en dos importantes eventos de inversores en septiembre de 2024. La empresa presentará en la 26ª Conferencia Anual Global de Inversión de H.C. Wainwright el 9 de septiembre a las 11:00 AM ET en Nueva York. Además, Compass participará en la Cantor Global Healthcare Conference el 17 de septiembre a las 8:35 AM ET, también en Nueva York.
Ambas presentaciones estarán disponibles a través de webcast, con enlaces proporcionados para cada evento. Los inversores y las partes interesadas pueden acceder a los webcasts a través de las URL especificadas. Las presentaciones se archivarão durante 90 días en la página de Eventos de Compass Therapeutics, permitiendo oportunidades de visualización extendidas. Estos eventos proporcionan una plataforma para que Compass muestre su progreso en el desarrollo de terapias basadas en anticuerpos para aplicaciones en oncología.
Compass Therapeutics (Nasdaq: CMPX)는 임상 단계의 종양학에 초점을 맞춘 생물제약 회사로, 2024년 9월 두 개의 주요 투자자 행사에 참여할 것이라고 발표했습니다. 회사는 9월 9일 오전 11시(ET)에 뉴욕에서 열리는 H.C. Wainwright 제26회 연례 글로벌 투자 컨퍼런스에서 발표할 예정입니다. 추가로, Compass는 9월 17일 오전 8시 35분(ET)에 뉴욕에서 열리는 Cantor Global Healthcare Conference에도 참여할 것입니다.
두 발표 모두 웹캐스트를 통해 제공되며, 각 행사에 대한 링크가 제공됩니다. 투자자와 관심 있는 당사자는 특정 URL을 통해 웹캐스트에 접근할 수 있습니다. 발표 자료는 Compass Therapeutics의 행사 페이지에 90일 동안 아카이빙되어 연장된 보기 기회를 제공합니다. 이러한 행사는 Compass가 항체 기반 치료제를 종양학적 응용을 위해 개발하는 진행 상황을 보여줄 수 있는 플랫폼을 제공합니다.
Compass Therapeutics (Nasdaq: CMPX), une entreprise biopharmaceutique axée sur l'oncologie et en phase clinique, a annoncé sa participation à deux événements majeurs pour investisseurs en septembre 2024. L'entreprise présentera lors de la 26e Conférence Annuelle Mondiale d'Investissement H.C. Wainwright le 9 septembre à 11h00 ET à New York. De plus, Compass participera à la Conférence Mondiale sur la Santé de Cantor le 17 septembre à 8h35 ET, également à New York.
Les deux présentations seront disponibles par webcast, avec des liens fournis pour chaque événement. Les investisseurs et les parties intéressées peuvent accéder aux webcasts via les URL spécifiées. Les présentations seront archivées pendant 90 jours sur la page Événements de Compass Therapeutics, permettant des possibilités de visionnage prolongées. Ces événements fournissent une plateforme à Compass pour mettre en valeur ses avancées dans le développement de thérapeutiques basées sur des anticorps pour des applications oncologiques.
Compass Therapeutics (Nasdaq: CMPX), ein biopharmazeutisches Unternehmen in der klinischen Phase mit Schwerpunkt auf Onkologie, hat seine Teilnahme an zwei wichtigen Investorenevents im September 2024 bekannt gegeben. Das Unternehmen wird am 9. September um 11:00 Uhr ET in New York auf der 26. Jahrestagung der globalen Investmentkonferenz von H.C. Wainwright präsentieren. Außerdem wird Compass am 17. September um 8:35 Uhr ET ebenfalls in New York an der Cantor Global Healthcare Conference teilnehmen.
Beide Präsentationen werden über einen Webcast verfügbar sein, wobei Links für jede Veranstaltung bereitgestellt werden. Investoren und Interessierte können über die angegebenen URLs auf die Webcasts zugreifen. Die Präsentationen werden 90 Tage lang auf der Event-Seite von Compass Therapeutics archiviert, was erweiterte Anzeigemöglichkeiten bietet. Diese Veranstaltungen bieten Compass eine Plattform, um seine Fortschritte bei der Entwicklung von therapiebasierten Antikörpern für onkologische Anwendungen zu präsentieren.
- None.
- None.
BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2024.
Details are as follows:
H.C. Wainwright 26th Annual Global Investment Conference
Location: New York, NY
Date: Monday, September 9, 2024
Time: 11:00am ET
Webcast Link: https://journey.ct.events/
Cantor Global Healthcare Conference
Location: New York, NY
Date: Tuesday, September 17, 2024
Time: 8:35am ET
Webcast Link: https://wsw.com/webcast/cantor
Virtual/Replay availability: Presentations will be archived for 90 days on Compass’ Events page.
About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.
Investor Contact
ir@compasstherapeutics.com
Media Contact
Anna Gifford, Senior Communications Manager
media@compasstherapeutics.com
617-500-8099
FAQ
When is Compass Therapeutics (CMPX) presenting at the H.C. Wainwright Global Investment Conference in 2024?
What is the date and time of Compass Therapeutics' (CMPX) presentation at the Cantor Global Healthcare Conference in 2024?
How long will the webcasts of Compass Therapeutics' (CMPX) investor presentations be available for replay?
Where can investors access the webcast links for Compass Therapeutics' (CMPX) September 2024 investor events?
